Covered recipient · General Payments record
EVELYN M HORN
Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology
General Payments · PY2018–2024
$10,692.43
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,100.00 | 1 |
| Food and Beverage | $1,191.97 | 13 |
| Education | $10.85 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOTRONIK INC. | $2,356.59 | 6 |
| Abbott Laboratories | $531.22 | 5 |
| Paragonix Technologies, Inc. | $247.69 | 1 |
| ABIOMED | $135.77 | 1 |
| Medtronic, Inc. | $20.70 | 1 |
| Merck Sharp & Dohme Corporation | $10.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.62 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125338838 | CMS |
| Abbott Laboratories | $163.49 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125338840 | CMS |
| Abbott Laboratories | $170.91 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125338846 | CMS |
| Abbott Laboratories | $26.32 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125338842 | CMS |
| Abbott Laboratories | $147.88 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125338844 | CMS |
| ABIOMED | $135.77 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142197505 | CMS |
| BIOTRONIK INC. | $179.81 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145801659 | CMS |
| BIOTRONIK INC. | $24.33 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145801695 | CMS |
| BIOTRONIK INC. | $8.72 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145801697 | CMS |
| BIOTRONIK INC. | $19.43 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145801699 | CMS |
| BIOTRONIK INC. | $24.30 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145801701 | CMS |
| BIOTRONIK INC. | $2,100.00 | 11/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1145801721 | CMS |
| Medtronic, Inc. | $20.70 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119548231 | CMS |
| Merck Sharp & Dohme LLC | $10.85 | 08/20/2024 | Education | Undisputed | 01/23/2026 | 1141710695 | CMS |
| Paragonix Technologies, Inc. | $247.69 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101026330 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.